Optimal induction, consolidation and maintenance before and after autologous stem cell transplantation in 2016

被引:0
|
作者
Blade, J. [1 ]
机构
[1] IDIBAPS Hosp Clin, Amiloidosis & Myeloma Unit, Barcelona, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
WP28
引用
收藏
页码:S106 / S107
页数:2
相关论文
共 50 条
  • [31] Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma
    Yan, Fengting
    Gopal, Ajay K.
    Graf, Solomon A.
    PHARMACEUTICALS, 2017, 10 (01)
  • [32] PET/CT before autologous stem cell transplantation predicts
    Alcantara, Marion
    Dupuis, Jehan
    Mareschal, Sylvain
    Julian, Anne
    Cottereau, Anne Segolene
    Becker, Stephanie
    Dubois, Sydney
    Oberic, Lucie
    Huynh, Anne
    Meignan, Michel
    Laurent, Guy
    Tilly, Herve
    Haioun, Corinne
    Ysebaert, Loic
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) : 215 - 221
  • [33] Autologous gamete cryopreservation before hemopoletic stem cell transplantation
    Nagashima, T
    Muroi, K
    Kawano-Yamamoto, C
    Miyoshi, T
    Ohmine, K
    Toshima, M
    Miyazato, A
    Takatoku, M
    Nagai, T
    Mori, M
    Komatsu, N
    Ozawa, K
    MEDICAL SCIENCE MONITOR, 2005, 11 (03): : CR91 - CR94
  • [34] Sensitivity of human bone marrow progenitors to stem cell factor before and after autologous stem cell transplantation.
    Herault, O
    Domenech, J
    Estienne, MH
    Linassier, C
    Colombat, P
    Binet, C
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 145 - 145
  • [35] Allogeneic hematopoietic cell transplantation as consolidation immunotherapy of cancer after autologous transplantation
    Maris, MB
    Storb, R
    ACTA HAEMATOLOGICA, 2005, 114 (04) : 221 - 229
  • [36] Nonmyeloablative conditioning and allogeneic stem cell transplantation as consolidation therapy after high-dose melphalan and autologous stem cell transplantation for multiple myeloma
    Schneider, P
    Fenk, R
    Bernhard, A
    Huenerlituerkoglu, AN
    Aivado, M
    Wehmeier, A
    Pape, H
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S101 - S101
  • [37] Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
    Baertsch, Marc-Andrea
    Mai, Elias K.
    Hielscher, Thomas
    Bertsch, Uta
    Salwender, Hans J.
    Munder, Markus
    Fuhrmann, Stephan
    Duehrsen, Ulrich
    Brossart, Peter
    Neben, Kai
    Schlenzka, Jana
    Kunz, Christina
    Raab, Marc S.
    Hillengass, Jens
    Jauch, Anna
    Seckinger, Anja
    Hose, Dirk
    Luntz, Steffen
    Sonneveld, Pieter
    Lokhorst, Henk
    Martin, Hans
    Goerner, Martin
    Hoffmann, Martin
    Lindemann, Hans-Walter
    Bernhard, Helga
    Blau, Igor W.
    Scheid, Christof
    Besemer, Britta
    Weisel, Katja C.
    Haenel, Mathias
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD CANCER JOURNAL, 2021, 11 (01)
  • [38] Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Li, Zhiguo
    Sung, Anthony D.
    Sarantopoulos, Stefanie
    Kang, Yubin
    Long, Gwynn D.
    Horwitz, Mitchell E.
    Lopez, Richard D.
    Sullivan, Keith M.
    Rizzieri, David A.
    Chao, Nelson J.
    Gasparetto, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 262 - 268
  • [39] Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation
    Nakamura, H
    Nakao, T
    Ujiie, H
    Karasuno, T
    Teshima, H
    Komatsu, K
    Ishiguro, S
    Hiraoka, A
    Masaoka, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) : S457 - S461
  • [40] Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
    Ma, Panelyi
    Xiao, Xiubin
    Yuan, Shunzong
    Chen, Xilin
    Zhao, Shihua
    Cheng, Nana
    Lu, Yun
    Chen, Junli
    Wang, Yueqi
    Huang, Wenrong
    BLOOD, 2023, 142